Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6492385B2 · kind B2 · utility
37Cited by
33References
97Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2001 |
| Grant date | Dec 10, 2002 |
| Priority date | — |
| Expiry date | Aug 17, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.